In our analysis, several coding and non-coding transcripts were identified, and they can be used as early biomarkers for the prognosis for several cardiomyopathies, for example, Mhrt in cardiac hypertrophy and heart failure, Meg3 in cardiac fibrosis, Snhg5 in vascular cerebral homeostasis, among others. This evidence concerns the gene SNHG5 and cardiac hypertrophy.